ClinicalTrials.Veeva

Menu

Three-dimensional Choroidal Vascularity Index in Common Fundus Diseases

W

Wuhan University

Status

Unknown

Conditions

Choroid

Treatments

Other: no intervention

Study type

Observational

Funder types

Other

Identifiers

NCT04790084
3DCVICFD

Details and patient eligibility

About

Explore the changes of choroidal blood perfusion in common fundus diseases by three-dimensional choroidal vascularity index, an optical coherence tomography (OCT) parameter.

Full description

Compared with the choroidal vascularity index on a single OCT image, the three-dimensional choroidal vascularity index can evaluate the choroidal changes of chorioretinal diseases as a whole. In this study, the choroidal changes of patients with common fundus diseases were systematically evaluated by collecting OCT and optical coherence tomography angiography (OCTA) images of patients with common fundus diseases, especially in healthy people, myopic people and patients with central serous chorioretinopathy.

Enrollment

300 estimated patients

Sex

All

Ages

10 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

  1. Healthy participants (1) Inclusion Criteria: 1) without systemic diseases such as diabetes and hypertension 2) best corrected visual acuity BCVA ≥ 1.0 3) aged 18 years or older (2) Exclusion criteria: 1) equivalent spherical refraction between -3 diopters and + 1.0 diopters 2) any visible lesions in the retina, optic nerve, or choroid 3) history of refractive or intraocular surgery
  2. Myopia group (1) Inclusion Criteria: 1) equivalent spherical refraction greater than -0.25 diopters 2) without systemic diseases such as diabetes and hypertension 3) Best corrected visual acuity (BCVA) ≥ 1.0 4) aged 10 years or older (2) Exclusion criteria: 1) history of refractive or intraocular surgery 2) history of laser therapy 3) other systemic diseases that may affect the choroid
  3. Central serous chorioretinopathy (CSC) group (1) Inclusion Criteria: 1) a diagnosis of CSC (2) Exclusion criteria: 1) high myopia or hyperopia (greater than 26 or +3 diopters of refractive error) 3) other systemic diseases that may affect the choroid 4) any other associated retinal pathology 5) history of refractive or intraocular surgery

Trial design

300 participants in 1 patient group

Healthy-Myopia-CSC
Description:
Cross-sectional study, no intervention, only collecting OCT,OCTA images and other eye parameters of patients.
Treatment:
Other: no intervention

Trial contacts and locations

1

Loading...

Central trial contact

GP Sun, MD; CZ Chen, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems